G6PDH Mutant Hapten Conjugates for Consistent Immunoassay Reagents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting small molecule haptens, such as small molecule drugs and hormones, face challenges including radioactive contamination, high costs, cumbersome procedures, and batch-to-batch variation due to inconsistent coupling sites in enzyme conjugation, making them unsuitable for clinical use.
Innovation Solution
A glucose 6-phosphate dehydrogenase (G6PDH) mutant with specific mutations (56C, 306C, and 454C) is conjugated with haptens at a controlled molar ratio to create a detection reagent, ensuring consistent and efficient hapten detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If enzyme conjugation with haptens is performed using prior art methods, then detection capability is achieved, but batch-to-batch variation occurs due to inconsistent coupling sites
Solution Approach 1:
The patent introduces specific point mutations (C56, C306, C454) in the G6PDH enzyme sequence to create consistent coupling sites. By changing the amino acid sequence parameters at specific positions, the invention ensures uniform hapten conjugation across different batches, resolving the batch-to-batch variation problem while maintaining detection capability
Solution Approach 2:
The patent creates a standardized enzyme mutant structure that serves as a consistent template for hapten conjugation. By copying the same mutation pattern (C56, C306, C454) across all enzyme preparations, the invention ensures reproducible coupling sites and eliminates variability between batches
2Productivity
If multiple small molecule haptens are linked to a single enzyme, then conjugation efficiency increases, but coupling site consistency deteriorates
Solution Approach 1:
The patent applies local quality by introducing specific cysteine mutations at defined positions (C56, C306, C454) in the enzyme structure. These localized modifications create specific, consistent coupling sites that maintain uniformity even when multiple haptens are conjugated, allowing high productivity without sacrificing precision
3Measurement precision
If conventional detection methods are used, then detection capability is achieved, but operational complexity and time consumption increase
Solution Approach 1:
The patent extracts and eliminates the need for complex sample preparation and multiple washing steps by using a homogeneous assay format. The enzyme-labeled hapten competes directly with sample hapten for antibody binding in solution, and detection is performed in a single step by measuring enzyme activity, dramatically simplifying operation while maintaining detection precision
4Measurement precision
If competitive ELISA method is used for hapten detection, then detection is possible, but time consumption and procedural complexity increase
Solution Approach 1:
The patent implements continuous useful action by using an enzyme-labeled hapten that maintains active enzyme function throughout the assay. The enzyme continuously converts substrate to product, providing a continuous signal that eliminates the need for multiple incubation and washing steps, reducing detection time while preserving accuracy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The G6PDH mutant conjugate provides improved repeatability, linearity, and specificity in hapten detection, reducing batch-to-batch variation and operational complexity, suitable for clinical use in enzyme-linked immunoassays.
Implementation Method 1
the enzyme-labeled antigen competes with the non-labeled antigen in a liquid homogeneous reaction system for binding to certain amount of antibody; the more the antibody binds to the non-labeled antigen, the more activity released by the enzyme-labeled antigen is and the more the NADH generated by enzymatic substrate NAD+
Implementation Method 2
the more the NADH generated by enzymatic substrate NAD+
Implementation Method 3
Haptens can bind to the corresponding antibody to produce an antigen-antibody reaction
Implementation Method 4
The content of the hapten in the liquid can be estimated by detecting the absorbance change at the wavelength of 340 nm
Data Source
AI summary
Disclosed is a glucose-6-phosphate dehydrogenase mutant and a use thereof in preparing a detection reagent. Compared with a wild-type glucose-6-phosphate dehydrogenase mutant, the glucose-6-phosphate dehydrogenase mutant contains a combination of the following mutations: 56C, 306C, and 454C. A detection kit prepared by using the glucose-6-phosphate dehydrogenase has strong specificity, high sensitivity, convenient operation, a short detection time, accurate quantification, and is suitable for high-throughput detection.